Le Lézard
Classified in: Health
Subjects: NPT, CHI

Karo Pharma Supports Operation Smile


HUDDINGE, Sweden, March 23, 2018 /PRNewswire/ --

Karo Pharma has decided to support Operation Smile with a donation of 2,5 MSEK. The Chairman of Karo Pharma will make a private donation of the same amount. The total sum of 5 MSEK enables more than 2000 surgeries of children suffering from lip and cleft palate. In addition, the company has decided to donate 3% of the netsales from Babyslide® during 3 years to the same organization.

" It feels really good to be able to make this donation to Operation Smile who is doing such an important effort for children suffering from lip and cleft palate." says Anders Lönner, Chairman of Karo Pharma.

Operation Smile is a medical aid organization that performs free surgeries on children and young people suffering from severe facial malformations, especially cleft lip and cleft palates. Operation Smile was founded in 1982 by the American plastic surgeon, Bill Magee and the nurse and social worker Kathy Magee.

About Karo Pharma 

Karo Pharma is a specialty pharma company that develops and markets products to pharmacies and directly to healthcare providers. The share is listed on Nasdaq Stockholm in the Mid Cap segment.

This press release is also available on www.newsroom.cision.com

CONTACT:

Karo Pharma
Nybrokajen 7, 111 48 Stockholm Sweden
+46-8-608-60-00
http://www.karopharma.se  
[email protected]

This information was brought to you by Cision http://news.cision.com
http://news.cision.com/karo-pharma/r/karo-pharma-supports-operation-smile,c2479175

The following files are available for download:

http://mb.cision.com/Main/72/2479175/810213.pdf

Press release (PDF)

 


These press releases may also interest you

at 20:31
Fitness International, LLC opened a new Club Studio location in Kingwood, Texas. The new 40,000 square foot club features five innovative boutique fitness studios that were carefully curated to create a unique experience, along with recovery services...

at 19:35
Mirum Pharmaceuticals, Inc. today announced that on May 10, 2024, the Compensation Committee of Mirum's Board of Directors granted inducement awards consisting of non-qualified stock options to purchase 38,600 shares of common stock and 19,300...

at 19:00
Evolus, Inc. , a performance beauty company with a focus on building an aesthetic portfolio of consumer brands, today reported the grant of non-qualified stock options to purchase an aggregate of 10,990 shares of Evolus and an aggregate of 42,759...

at 18:36
Inhibrx, Inc. ("Inhibrx," or the "Company") today announced that in connection with the previously announced distribution by the Company of 92% of shares of common stock of its subsidiary Inhibrx Biosciences, Inc. ("SpinCo") to holders of shares of...

at 17:55
Asia Green Biotechnology Corp. ("Asia Green" or the "Company") announces that, further to its news releases dated April 17, 2024, April 26, 2024, and May 8, 2024, the Management Cease Trade Order ("MCTO") issued by the...

at 17:53
The following statement is being issued by Rice Harbut Elliott LLP regarding the Ruckman v. Biotrade Canada Ltd. et al. lawsuit: All persons in Canada who purchased or ingested U-Dream on or after August 18, 2014 (the "Class" or "Class Members")...



News published on and distributed by: